How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
28
AIP Quote, Financials, Valuation and Earnings
Last price:
$6.91
Seasonality move
:
8.49%
Day range:
$7.09 - $7.64
52-week range:
$5.76 - $12.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.78x
P/B ratio:
184.43x
Volume:
132.6K
Avg. volume:
201.7K
1-year change:
-3.14%
Market cap:
$290.3M
Revenue:
$57.7M
EPS (TTM):
-$0.87
Analysts' Opinion
-
Consensus RatingArteris has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $13.20, Arteris has an estimated upside of 93.94% from its current price of $7.09.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 100% downside risk from its current price of $7.09.
Fair Value
-
According to the consensus of 5 analysts, Arteris has 93.94% upside to fair value with a price target of $13.20 per share.
AIP vs. S&P 500
-
Over the past 5 trading days, Arteris has underperformed the S&P 500 by -8.51% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Arteris does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Arteris has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Arteris reported revenues of $15.5M.
Earnings Growth
-
Arteris has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Arteris reported earnings per share of -$0.20.
Enterprise value:
248.6M
EV / Invested capital:
--
Price / LTM sales:
4.78x
EV / EBIT:
--
EV / Revenue:
4.31x
PEG ratio (5yr expected):
-4.20x
EV / Free cash flow:
-238.08x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$51.8M
Return On Assets:
-33.35%
Net Income Margin (TTM):
-58.27%
Return On Equity:
-543.51%
Return On Invested Capital:
-381.39%
Operating Margin:
-45.85%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $50.4M | $53.7M | $57.7M | $12.5M | $15.5M | |
| Gross Profit | $46.1M | $48.6M | $51.8M | $11.1M | $13.9M | |
| Operating Income | -$28.9M | -$35.1M | -$31.6M | -$9.2M | -$7.1M | |
| EBITDA | -$25.3M | -$28.5M | -$24.8M | -$7.5M | -$5.4M | |
| Diluted EPS | -$0.84 | -$1.03 | -$0.87 | -$0.28 | -$0.20 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29M | $106.6M | $81.1M | $58.4M | $69.1M | |
| Total Assets | $42.7M | $120.4M | $115.5M | $102.8M | $106.1M | |
| Current Liabilities | $28.2M | $42.5M | $43.7M | $46.4M | $59.3M | |
| Total Liabilities | $54.7M | $67.5M | $78M | $87.7M | $107.3M | |
| Total Equity | -$12M | $52.9M | $37.5M | $15.1M | -$1.2M | |
| Total Debt | $1.9M | $1.1M | $1.7M | $3.4M | $2.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$6.8M | -$15.7M | -$720K | -$3M | -$2.6M | |
| Cash From Investing | -$37.5M | -$4.7M | $970K | -$1.4M | -$1.9M | |
| Cash From Financing | -$4.2M | -$2.9M | -$262K | -$584K | $414K | |
| Free Cash Flow | -$7.8M | -$17.2M | -$1M | -$3.4M | -$2.7M | |
AIP
Sector
Market Cap
$290.3M
$84.5M
Price % of 52-Week High
56.09%
57.88%
Dividend Yield
0%
0%
Shareholder Yield
--
0.8%
1-Year Price Total Return
-3.14%
-19.03%
Beta (5-Year)
--
0.910
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.77
200-day SMA
Sell
Level
$8.45
Bollinger Bands (100)
Sell
Level
7.86 - 10.7
Chaikin Money Flow
Buy
Level
12.3M
20-day SMA
Sell
Level
$7.89
Relative Strength Index (RSI14)
Sell
Level
30.97
ADX Line
Sell
Level
25.85
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$9.37
MACD (12, 26)
Sell
Level
-0.47
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
10.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.2924)
Sell
CA Score
(Annual)
Level (-3.4551)
Buy
Beneish M-Score
(Annual)
Level (-3.3521)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (5.8347)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.
Stock Forecast FAQ
In the current month, AIP has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AIP average analyst price target in the past 3 months is $13.20.
-
Where Will Arteris Stock Be In 1 Year?
According to analysts, the consensus estimate is that Arteris share price will rise to $13.20 per share over the next 12 months.
-
What Do Analysts Say About Arteris?
Analysts are divided on their view about Arteris share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arteris is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Arteris's Price Target?
The price target for Arteris over the next 1-year time period is forecast to be $13.20 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AIP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Arteris is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AIP?
You can purchase shares of Arteris via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arteris shares.
-
What Is The Arteris Share Price Today?
Arteris was last trading at $6.91 per share. This represents the most recent stock quote for Arteris. Yesterday, Arteris closed at $7.09 per share.
-
How To Buy Arteris Stock Online?
In order to purchase Arteris stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 31
Ajinomoto [AJINY] is down 2.15% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
69
AGX alert for Mar 31
Argan [AGX] is down 4.98% over the past day.
